Liver Resection Promotes (Regulates) Proinflammatory Cytokines in Patients with Hepatocellular Carcinoma
Overview
Affiliations
Background: Several animal studies have shown the roles of cytokines in regulating liver regeneration following liver resection (LR), which is a type of surgery designed to remove cancerous tumors from the liver. This study investigated how the expressions and serum levels of some pro- and anti-inflammatory cytokines in patients with hepatocellular carcinoma (HCC) were changed during LR.
Methods: Liver tissues from 15 patients with HCC were collected and the levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-), IL-1, IL-1 , IL-10, and transforming growth factor-beta1 (TGF-1) were assessed using real-time PCR assay at different times before and after LR. The serum values of TNF- and IL-6 were also measured by ELISA.
Results: After 60 and 90 minutes of LR, IL-6 gene expression was significantly increased ( < 0.001 - 0.05). The same trend was also observed in TNF- expression after 90 minutes of LR ( < 0.01). No significant changes were observed in the expressions of IL-1, IL-1, IL-10, and TGF-1 before and after LR. In addition, LR had significant effects on TNF- and IL-6 serum levels ( < 0.05 - 0.0001).
Conclusion: Our data provided further evidence to reveal that IL-6 and TNF- cytokines are critical to improve liver regeneration.
Signaling pathways of liver regeneration: Biological mechanisms and implications.
Zhang C, Sun C, Zhao Y, Ye B, Yu G iScience. 2023; 27(1):108683.
PMID: 38155779 PMC: 10753089. DOI: 10.1016/j.isci.2023.108683.
Sun H, Wang H, Wang Y, Zhong W, Meng Y, Lv Z Front Oncol. 2023; 13:1129065.
PMID: 36969018 PMC: 10034130. DOI: 10.3389/fonc.2023.1129065.
Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?.
Luo L, He Y, Zhu G, Xiao Y, Song S, Ge X J Hepatocell Carcinoma. 2022; 9:1353-1368.
PMID: 36578526 PMC: 9792109. DOI: 10.2147/JHC.S388965.
Xie C, Zhang Z, Yang M, Cao C, Zhou Y, Zhu Z Front Microbiol. 2022; 12:800470.
PMID: 35154031 PMC: 8834300. DOI: 10.3389/fmicb.2021.800470.
Esagian S, Kakos C, Giorgakis E, Burdine L, Barreto J, Mavros M Cancers (Basel). 2021; 13(12).
PMID: 34203692 PMC: 8232114. DOI: 10.3390/cancers13122984.